SCHEMBL30273650

SCHEMBL30273650

COC(=O)C1CCN(c2ccc3c4c(cccc24)C(=O)N(OS(=O)(=O)c2ccc(C)cc2)C3=O)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.52
ALDH1A1 P00352 6/20 0.52
HPGD P15428 5/20 0.52
VDR P11473 2/20 0.49
MAPT P10636 8/20 0.48
KMT2A Q03164 6/20 0.48
MEN1 O00255 5/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
POLB P06746 1/20 0.48
BRD1 O95696 2/20 0.43
TAF1 P21675 2/20 0.43
BRPF1 P55201 2/20 0.43
NSD2 O96028 1/20 0.43
MAPK1 P28482 1/20 0.43
ATM Q13315 1/20 0.42
LMNA P02545 2/20 0.40
THRB P10828 1/20 0.40
HTT P42858 1/20 0.40
F2 P00734 1/20 0.39
BRD4 O60885 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31397357 0.87 ALDH1A1 (0.49) KDM4EALDH1A1HPGDVDRMAPT
SCHEMBL30273729 0.81 KMT2A (0.50) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL30273799 0.78 KDM4E (0.49) KDM4EALDH1A1HPGDVDRMAPT
SCHEMBL30274009 0.78 ALDH1A1 (0.53) KDM4EALDH1A1HPGDVDRMAPT
SCHEMBL30273763 0.77 MEN1 (0.46) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL17231447 0.75 KDM4E (0.72) KDM4EALDH1A1HPGDVDRMAPT
SCHEMBL24943443 0.74 KDM4E (0.67) KDM4EALDH1A1HPGDVDRMAPT
SCHEMBL26546204 0.74 KDM4E (0.61) KDM4EALDH1A1HPGDVDRMAPT
SCHEMBL17231436 0.72 KDM4E (0.67) KDM4EALDH1A1HPGDVDRMAPT
SCHEMBL26546218 0.72 KDM4E (0.57) KDM4EALDH1A1HPGDVDRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250302815-A1 PROTEIN TYROSINE PHOSPHATASE TARGETING LIGANDS CALICO LIFE SCIENCES LLC 2025-10-02 US disclosed
WO-2023019166-A1 PROTEIN TYROSINE PHOSPHATASE TARGETING LIGANDS CALICO LIFE SCIENCES LLC (US) 2023-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250302815-A1 PROTEIN TYROSINE PHOSPHATASE TARGETING LIGANDS PTPN1, PTPN2, PTPN18 KDM4E 2019/4885ALDH1A1 3874/4885HPGD 3365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.